Similar articles for PMID: 20484439

Year	Number of Results
1990	1
1996	1
1999	1
2000	3
2001	4
2002	1
2003	4
2004	14
2005	7
2006	1
2007	5
2008	4
2009	5
2010	17
2011	13
2012	6
2013	3
2014	7
2015	6
2016	8
2017	6
2018	2
2019	3
2020	2
2024	0

1

Immuno-PET quantitation of de2-7 epidermal growth factor receptor expression in glioma using 124I-IMP-R4-labeled antibody ch806.

Lee FT, O'Keefe GJ, Gan HK, Mountain AJ, Jones GR, Saunder TH, Sagona J, Rigopoulos A, Smyth FE, Johns TG, Govindan SV, Goldenberg DM, Old LJ, Scott AM. Lee FT, et al. J Nucl Med. 2010 Jun;51(6):967-72. doi: 10.2967/jnumed.109.068395. Epub 2010 May 19. J Nucl Med. 2010. PMID: 20484439 Free article.

2

¹²⁴I-Labeled residulizing ligand IMP-R4 conjugated chimeric monoclonal antibody ch806 targeting the epidermal growth factor receptor deletion variant de2-7 (EGFRvIII).

Chopra A. Chopra A. 2010 Jun 26 [updated 2010 Aug 5]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. 2010 Jun 26 [updated 2010 Aug 5]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. PMID: 20698075 Free Books & Documents. Review.

3

L-Tyrosine Confers Residualizing Properties to a d-Amino Acid-Rich Residualizing Peptide for Radioiodination of Internalizing Antibodies.

Lee FT, Burvenich IJ, Guo N, Kocovski P, Tochon-Danguy H, Ackermann U, O'Keefe GJ, Gong S, Rigopoulos A, Liu Z, Gan HK, Scott AM. Lee FT, et al. Mol Imaging. 2016 Jul 25;15:1536012116647535. doi: 10.1177/1536012116647535. Print 2016. Mol Imaging. 2016. PMID: 27457521 Free PMC article.

4

Immuno-PET of human colon xenograft- bearing BALB/c nude mice using 124I-CDR-grafted humanized A33 monoclonal antibody.

Lee FT, Hall C, Rigopoulos A, Zweit J, Pathmaraj K, O'Keefe GJ, Smyth FE, Welt S, Old LJ, Scott AM. Lee FT, et al. J Nucl Med. 2001 May;42(5):764-9. J Nucl Med. 2001. PMID: 11337573 Free article.

5

PET imaging of HER1-expressing xenografts in mice with 86Y-CHX-A''-DTPA-cetuximab.

Nayak TK, Regino CA, Wong KJ, Milenic DE, Garmestani K, Baidoo KE, Szajek LP, Brechbiel MW. Nayak TK, et al. Eur J Nucl Med Mol Imaging. 2010 Jul;37(7):1368-76. doi: 10.1007/s00259-009-1370-z. Epub 2010 Feb 13. Eur J Nucl Med Mol Imaging. 2010. PMID: 20155263 Free PMC article.

6

¹¹¹In-Labeled chimeric monoclonal antibody, ch806, targeting the epidermal growth factor receptor deletion variant de2-7 (EGFRvIII).

Chopra A. Chopra A. 2010 Jul 6 [updated 2010 Aug 26]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. 2010 Jul 6 [updated 2010 Aug 26]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. PMID: 20806449 Free Books & Documents. Review.

7

¹²⁵I-Labeled chimeric monoclonal antibody, ch806, targeting the epidermal growth factor receptor deletion variant de2-7 (EGFRvIII).

Chopra A. Chopra A. 2010 Jul 6 [updated 2010 Aug 26]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. 2010 Jul 6 [updated 2010 Aug 26]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. PMID: 20806447 Free Books & Documents. Review.

8

PET imaging of EGFR expression in nude mice bearing MDA-MB-468, a human breast adenocarcinoma.

Sadri K, Ren Q, Zhang K, Paudyal B, Devadhas D, Rodeck U, Thakur M. Sadri K, et al. Nucl Med Commun. 2011 Jul;32(7):563-9. doi: 10.1097/MNM.0b013e3283419523. Nucl Med Commun. 2011. PMID: 21572364

9

Engineering and characterisation of chimeric monoclonal antibody 806 (ch806) for targeted immunotherapy of tumours expressing de2-7 EGFR or amplified EGFR.

Panousis C, Rayzman VM, Johns TG, Renner C, Liu Z, Cartwright G, Lee FT, Wang D, Gan H, Cao D, Kypridis A, Smyth FE, Brechbiel MW, Burgess AW, Old LJ, Scott AM. Panousis C, et al. Br J Cancer. 2005 Mar 28;92(6):1069-77. doi: 10.1038/sj.bjc.6602470. Br J Cancer. 2005. PMID: 15770208 Free PMC article.

10

The efficacy of epidermal growth factor receptor-specific antibodies against glioma xenografts is influenced by receptor levels, activation status, and heterodimerization.

Johns TG, Perera RM, Vernes SC, Vitali AA, Cao DX, Cavenee WK, Scott AM, Furnari FB. Johns TG, et al. Clin Cancer Res. 2007 Mar 15;13(6):1911-25. doi: 10.1158/1078-0432.CCR-06-1453. Clin Cancer Res. 2007. PMID: 17363548 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

99 results

Results by year